64416-07-5

Basic information

• Product Name: Cyclohexane, 4-(methoxymethylene)-1,1-dimethyl-
• CAS NO: 64416-07-5
• Molecular Formula: C10H18O
• Molecular Weight: 154.252
• Mol File: 64416-07-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Cyclohexane, 4-(methoxymethylene)-1,1-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexane, 4-(methoxymethylene)-1,1-dimethyl-(64416-07-5)
• EPA Substance Registry System: Cyclohexane, 4-(methoxymethylene)-1,1-dimethyl-(64416-07-5)

Safety Data

• Hazardous Substances Data: 64416-07-5(Hazardous Substances Data)

Upstream product

• 4255-62-3 4,4-dimethylcyclohexane-1-one 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 
• 1073-13-8 4,4-dimethylcyclohexenone 
• 33670-32-5 methoxymethyltriphenylphosphonium bromide 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 

Downstream Products

• 1007578-77-9 [(4,4-dimethylcyclohexyl)methyl]amine hydrochloride 
• 1007578-76-8 [(4,4-dimethylcyclohexyl)methyl](phenylmethyl)amine 
• 140423-42-3 1,4,4-trimethylcyclohexanecarbaldehyde 
• 1210879-13-2 C₁₁H₂₂O 
• 394734-96-4 4,4-dimethylcyclohexanecarbaldehyde 

Relevant articles and documents

OXYSTEROLS AND METHODS OF USE THEREOF

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

PYRAZOLE AMIDE DERIVATIVE

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.